Statins, metformin, and RAS inhibitors did not reduce variceal bleeding risk and mortality in a large, real-life cohort of patients with cirrhosis
Fig 4
Kaplan-Meier mortality curves with comedication (statin, metformin or RASi) or non-comedication for primary and secondary prophylaxis (A-F). n (total numbers), 1Y (Year 1), 2Y (Year 2), 3Y (Year 3), HR (Hazard-Ratio); 95% CI (95% confidence interval); n.s. (not significant); statistical comparisons were performed by log-rank tests.